December 16, 2025 · Form 4 insider transaction
Brady Todd C sold 27 shares of EVOK, a transaction worth N/A. The trade was recorded as u and disclosed on an SEC Form 4, filed 1 day after the transaction.
On December 16, 2025, in connection with that certain Agreement and Plan of Merger, dated as of November 3, 2025 (the "Merger Agreement"), by and among the Issuer, QOL Medical, LLC ("Parent") and QOL-EOS Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub" and together with Parent, the "Purchasers"), the Purchasers completed a tender offer to acquire all of the issued and outstanding shares of Common Stock of the Issuer in exchange for $11.00 per share in cash (the "Offer Price").